View Item 

Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy.

Access Status
Open access
Authors
Marini, S.
Susufi, Y.
Krisnuhoni, E.
Gani, R.
Yunihastuti, E.
Lee, Silvia
Tanaskovic, S.
Price, Patricia
Date
2016
Type
Journal Article

Metadata
Show full item record
Citation
Stephanie, M. and Susufi, Y. and Krisnuhoni, E. and Gani, R. and Yunihastuti, E. and Lee, S. and Tanaskovic, S. et al. 2016. Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy. AIDS Research and Human Retroviruses. 32 (12): pp. 1202-1204.
Source Title
AIDS Research and Human Retroviruses
DOI
School
School of Biomedical Sciences
Remarks

Final publication is available from Mary Ann Liebert, Inc., publishers http://doi.org/10.1089/AID.2016.0042

URI
Collection
Abstract

Coinfections with Hepatitis C virus and human immunodeficiency virus accelerate the progression of both conditions and hamper effective treatment. Here we describe expression of CXCR3 on liver-infiltrating cells and peripheral T cells from coinfected patients commencing antiretroviral therapy (ART) in Indonesia. CXCR3 was expressed by small number of intrahepatic inflammatory cells, mostly in the portal areas. The number of cells did not change on ART and was markedly lower than the number of CD4(+) and CD8(+) cells in the liver. Data suggest that CXCR3 may contribute to liver infiltration but demonstrate a dynamic situation, changing as the immune system recovers on ART.